Bis(quercetinato)oxovanadium IV reverses metabolic changes in streptozotocin-induced diabetic mice

Review of Diabetic Studies

Volumn 4, Issue 1, 2007, Pages 33-43

  Shukla, Ruchi ^a   Padhye, Subhash ^b   Modak, Manisha ^b   Ghaskadbi, Saroj S ^b   Bhonde, Ramesh R ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b UNIVERSITY OF PUNE   (India)

Author keywords

Glucokinase and G 6 Pase; Insulin mimetic; Oxidative stress; Pancreatic regeneration; Vanadium

Indexed keywords

BIS(QUERCETINATO)OXOVANADIUM IV; GLUCOKINASE; GLUCOSE 6 PHOSPHATASE; INSULIN; STREPTOZOCIN; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; KIDNEY FUNCTION TEST; LIVER; LIVER FUNCTION TEST; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS; RENAL PROTECTION; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

EID: 34548821581     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2007.4.33     Document Type: Article

References (34)

1. Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989. 38:550-557.
2. Kiss L, Szabo C. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity. Mem Inst Oswaldo Cruz 2005. 1:29-37.
3. Ceriello A. Oxidative stress and diabetes-associated complications Endocr Pract 2006. 12(Suppl 1):60-62.
4. Srivastava AK, Mehdi MZ. Insulino-mimetic and antidiabetic effects of vanadium compounds. Diabet Med 2005. 22:2-13.
5. Marzban L, Rahimian R, Brownsey RW, McNeill JH. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo. Endocrinology 2002. 143:4636-4645.
6. Mohammad A, Sharma V, McNeill JH. Vanadium increases GLUT4 in diabetic rat skeletal muscle. Mol Cell Biochem 2002. 233:139-143.
7. Srivastava AK. Anti-diabetic and toxic effects of vanadium compounds. Mol Cell Biochem 2000. 206:177-182.
8. Scior T, Guevara-Garcia A, Bernard P, Do QT, Domeyer D, Laufer S. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review. Mini Rev Med Chem 2005. 5:995-1008.
9. Yuen VG, Orvig C, McNeill JH. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can J Physiol Pharmacol 1995. 73:55-64.
10. Domingo JL, Gomez M, Sanchez DJ, Llobet JM, Keen CL. Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation. Mol Cell Biochem 1995. 153:233-240.
11. Reul BA, Amin SS, Buchet JP, Ongemba LN, Crans DC, Brichard SM. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats. Br J Pharmacol 1999. 126:467-477.
12. Shukla R, Barve V, Padhye S, Bhonde R. Synthesis, structural properties and insulin-enhancing potential of bis(quercetinato)oxovanadium(IV) conjugate. Bioorg Med Chem Lett 2004. 14:4961-4965.
13. Shukla R, Barve V, Padhye S, Bhonde R. Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid, quercetin: A pragmatic therapeutic approach for diabetes. Biometals 2006. 19:685-693.
14. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med 1999. 26:1231-1237.
15. Arnous A, Makris DP, Kefalas P. Effect of principle polyphenolic components in relation to antioxidant characteristics of aged red wines. J Agri Food Chem 2001. 49:5736-5742.
16. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': The FRAP assay. Anal Biochem 1996. 239:70-76.
17. rd edition, Bermeyer HU, Verlagchemie GmbH, Weinhein 1993. 3:277-282.
18. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971. 44:276-287.
19. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 1976. 71:952-958.
20. Lefevre G. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Ann Biol Clin (Paris) 1998. 56(3):305-319.
21. Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J 2005. 386:471-478.
22. Brichard SM, Desbuquois B, Girard J. Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2. Mol Cell Endocrinol 1993. 91:91-97.
23. Ferre P, Leturque A, Burnol AF, Penicaud L, Girard J. A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J 1985. 228:103-110.
24. Ball SW, Bailey JR, Stewart JM, Vogels CM, Westcott SA. A fluorescent compound for glucose uptake measurements in isolated rat cardiomyocytes. Can J Physiol Pharmacol 2002. 80:205-209.
25. Koyama Y, Abe K, Sano Y, Ishizaki Y, Njelekela M, Shoji Y, Hara Y, Isemura M. Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Med 2004. 70:1100-1102.
26. Estrada O, Hasegawa M, Gonzalez-Mujica F, Motta N, Perdomo E, Solorzano A, Mendez J, Mendez B, Zea EG. Evaluation of flavonoids from Bauhinia megalandra leaves as inhibitors of glucose-6-phosphatase system Phytother Res 2005. 19:859-863.
27. Mahesh T, Menon VP. Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res 2004. 18:123-127.
28. Anjaneyulu M, Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004. 31:244-248.
29. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 2005. 135:2299-2304.
30. Koyuturk M, Tunali S, Bolkent S, Yanardag R. Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats. Boil Trace Elem Res 2005. 104:233-247.
31. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 2005. 51:117-123.
32. Bolkent S, Bolkent S, Yanardag R, Tunali S. Protective effect of vanadyl sulfate on the pancreas of streptozotocin induced diabetic rats. Diabetes Res Clin Pract 2005. 70:103-109.
33. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003. 135C(3):357-364.
34. Majithiya JB, Balaraman R, Giridhar R, Yadav MR. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats. J Trace Elem Med Biol 2005. 18:211-217.